Avai Bio (AVAI) Return on Capital Employed (2019 - 2025)

Avai Bio has disclosed Return on Capital Employed across 7 years of filings, most recently posting 153.43% for Q4 2025.

• Return on Capital Employed for Q4 2025 came in at 153.43%, down 634.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 153.43% (down 634.0% YoY), and the FY2025 annual result was 75.38%, down 6588.0% from the prior year.
• Return on Capital Employed came in at 153.43% for Q4 2025 at Avai Bio, up from 138.09% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 813.38% in Q3 2021 to a low of 135.74% in Q2 2022.
• The 5-year median for Return on Capital Employed is 78.42% (2025), against an average of 76.83%.
• Peak annual rise in Return on Capital Employed reached 70903 bps in 2021, while the deepest fall reached 149332 bps in 2021.
• Avai Bio's Return on Capital Employed stood at 36.79% in 2021, then decreased by 23 bps to 45.1% in 2022, then declined by 18 bps to 53.26% in 2023, then jumped by 400 bps to 159.76% in 2024, then fell by 4 bps to 153.43% in 2025.
• The last three Return on Capital Employed figures came in at 153.43% (Q4 2025), 138.09% (Q3 2025), and 110.7% (Q2 2025), per Business Quant data.